Bayraktar TB2 vs Archer in 2026

Bayraktar TB2

The Bayraktar TB2, from Turkey's Baykar, is the internationally fielded legacy-prime armed UAV and a remotely-piloted, AI-augmented-not-autonomous platform. It is a medium-altitude armed drone with 20-plus hours of endurance, a 25,000-foot ceiling, a 150-kilogram payload, and Roketsan MAM laser-guided munitions, with triple-redundant flight control that automates taxi, takeoff, cruise, and landing while the mission itself remains operator-supervised.

It is widely exported and combat-proven (Ukraine, Nagorno-Karabakh, the Libyan civil war, and others). The verified-vs-claimed nuance: Baykar's newer products (the Akinci HALE UCAV and the jet-powered Kizilelma) move toward greater autonomy, but the TB2 specifically is remotely-piloted, with a human operator supervising targeting and strike decisions.

It is defense procurement; there is no consumer price. Specific export-country counts and engagement claims vary by source and defer to primary disclosures.

Archer

Neros' Archer is a first-person-view (FPV) strike quadcopter from the 2023-founded, Los-Angeles-based new-defense maker, sold to defense customers rather than consumers, so there is no consumer price. Its verified gating events are strong for so new a company: selection for the US Army's Purpose-Built Attritable Systems (PBAS) program Tranche 1 in November 2025 as one of three primary FPV makers, a multi-million-dollar Marine Corps Archer Strike contract in December 2025, and roughly 6,000 Archers fielded to Ukraine via the Ramstein drone coalition at about 1,500 per month.

Two corrections the registry records and this page carries: the often-cited Replicator tie is not borne out (the verified program is Army PBAS plus Marine and DIU work), and the Archer is a human-piloted FPV drone, not autonomous (Series-B funds are earmarked for autonomy research that is aspirational, not fielded). Recorded at early commercial maturity on real product plus named contracts plus combat fielding; the aspirational scale figures (10,000 per month, one million per year) and the undisclosed PBAS value/quantity/timeline are not granted.